Zobrazeno 1 - 10
of 50
pro vyhledávání: '"misoprostol vaginal insert"'
Autor:
Daniele Bolla, Saskia Vanessa Weissleder, Anda-Petronela Radan, Maria Luisa Gasparri, Luigi Raio, Martin Müller, Daniel Surbek
Publikováno v:
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Misoprostol vaginal insert for induction of labor has been recently reported to be superior to dinoprostone vaginal insert in a phase III trial, but has never been compared to vaginal misoprostol in another galenic form. The aim o
Externí odkaz:
https://doaj.org/article/98d2181d933f45caabe73cf9a4775dab
Autor:
Maija-Riitta Ordén, Heidi Kruit, Emma Hokkila, Susanna Timonen, Liisa Laatio, Mirjami Mattila, Jukka Uotila, Kati Tihtonen, Leena Rahkonen, Tiina Luukkaala
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 98:1032-1039
Introduction: Our objective was to compare the efficacy of a 200‐μg misoprostol vaginal insert vs oral misoprostol regarding the cesarean section rate and the time interval to vaginal delivery in nulliparous women with unfavorable cervix. Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904835072a97261c2dcb4d6d615c8f1f
https://doi.org/10.1111/aogs.13580
https://doi.org/10.1111/aogs.13580
Autor:
Valentin Nicolae Varlas, Nicolae Bacalbasa, Anca Lucia Pop, Bogdana Adriana Năsui, Georgiana Bostan
Publikováno v:
Healthcare
Volume 9
Issue 4
Healthcare, Vol 9, Iss 464, p 464 (2021)
Volume 9
Issue 4
Healthcare, Vol 9, Iss 464, p 464 (2021)
Induction of labor (IOL) is an event that occurs in up to 25% of pregnancies. In Europe, the misoprostol vaginal insert (MVI—Misodel®) was approved for labor induction in 2013. Studies on the outcomes and safety of IOL in obese pregnant women are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02cd5b4e4ac3e02b9bc51c29058504f
Autor:
Döbert, Moritz
Einleitung: Geburten werden weltweit in 9,6% und in Deutschland in 20% eingeleitet. Eine etablierte Methode stellt dabei Misoprostol im off-label use dar. Die Zulassung des Misoprostol Vaginalinserts zur Geburtsinduktion veränderte jedoch die mediko
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e0b7282f8651d2799b60f80a7f71bd
https://refubium.fu-berlin.de/handle/fub188/29357
https://refubium.fu-berlin.de/handle/fub188/29357
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Stelmachowski, Izabela Pieniążek, Jacek Walczak, O. R. Baev, A. Bierut, K. Pacocha, Maciej Sobkowski, Jadwiga Dowgiałło-Smolarczyk
Publikováno v:
Advances in Therapy
Introduction The present study aimed to assess the costs and consequences of using an innovative medical technology, misoprostol vaginal insert (MVI), for the induction of labor (IOL), in place of alternative technologies used as a standard of care.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45789b91515ff6217e02bf62a4a63461
http://europepmc.org/articles/PMC5055557
http://europepmc.org/articles/PMC5055557
Publikováno v:
Bjog
Rugarn, O; Tipping, D; Powers, B; & Wing, DA. (2017). Induction of labour with retrievable prostaglandin vaginal inserts: outcomes following retrieval due to an intrapartum adverse event. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 124(5), 796-803. doi: 10.1111/1471-0528.14147. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2026z70s
Rugarn, O; Tipping, D; Powers, B; & Wing, DA. (2017). Induction of labour with retrievable prostaglandin vaginal inserts: outcomes following retrieval due to an intrapartum adverse event. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 124(5), 796-803. doi: 10.1111/1471-0528.14147. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2026z70s
Objective To assess adverse event (AE) resolution, delivery mode and neonatal outcomes after misoprostol or dinoprostone vaginal insert (MVI or DVI) retrieval due to AE during induction of labour (IOL). Design Randomised, double‐blind trial, EXPEDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff7adc4c350ebbb4f6da2dbc2a1d3f9
https://doi.org/10.1111/1471-0528.14147
https://doi.org/10.1111/1471-0528.14147
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Müller, D Bolla, Luigi Raio, Anda-Petronela Radan, Maria Luisa Gasparri, Daniel Surbek, Saskia Vanessa Weissleder
Publikováno v:
Bolla, Daniele; Weissleder, Saskia Vanessa; Radan, Anda-Petronela; Gasparri, Maria Luisa; Raio, Luigi; Müller, Martin; Surbek, Daniel (2018). Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study. BMC pregnancy and childbirth, 18(1), p. 149. BioMed Central 10.1186/s12884-018-1788-z
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Pregnancy and Childbirth
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Pregnancy and Childbirth
Background Misoprostol vaginal insert for induction of labor has been recently reported to be superior to dinoprostone vaginal insert in a phase III trial, but has never been compared to vaginal misoprostol in another galenic form. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3ae08687c263de1dd1d2b44c17be96
https://boris.unibe.ch/125737/1/29747591.pdf
https://boris.unibe.ch/125737/1/29747591.pdf